Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stemcelline Vial - WJ-Exo
- Development stage
- Preclinical
- Lead developer
- Stemcelline
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Stemcelline Vial - WJ-Exo is an investigational exosome-based therapy developed by Stemcelline, an Indian cellular bio-medical service center based in Faridabad, Haryana. The product consists of extracellular vesicles (exosomes) derived from Wharton's Jelly mesenchymal stem cells (WJ-MSCs) obtained from human umbilical cords. It is currently in the preclinical development stage for the treatment of pulmonary fibrosis. The therapy is designed to leverage the paracrine signaling properties of mesenchymal stem cells, delivering regenerative and immunomodulatory signals to restore tissue injury in the lungs. Stemcelline maintains research collaborations with several academic and medical institutions, including the University of Sheffield, University of Oxford, the All India Institute of Medical Sciences (AIIMS), and the Indian Institute of Science (IISc).
- Brand names
- Stemcelline Vial
- Other names
- Wharton's Jelly-derived extracellular vesiclesWJ-MSC-derived exosomesWJ-Exo-Stemcellineexosome therapy
Beyond the preview
Go deeper on Stemcelline Vial - WJ-Exo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stemcelline Vial - WJ-Exo.